IL-33 signalling in liver immune cells enhances drug-induced liver injury and inflammation

Maísa Mota Antunes,Alan Moreira Araújo,Ariane Barros Diniz,Rafaela Vaz Sousa Pereira,Débora Moreira Alvarenga,Bruna Araújo David,Renata Monti Rocha,Maria Alice Freitas Lopes,Sarah Cozzer Marchesi,Brenda Naemi Nakagaki,Érika Carvalho,Pedro Elias Marques,Bernhard Ryffel,Valérie Quesniaux,Rodrigo Guabiraba Brito,José Carlos Alves Filho,Denise Carmona Cara,Rafael Machado Rezende,Gustavo Batista Menezes
DOI: https://doi.org/10.1007/s00011-017-1098-3
IF: 6.986
2017-10-14
Inflammation Research
Abstract:Objective and designThe aim of this study was to investigate the contribution of IL-33/ST2 axis in the onset and progression of acute liver injury using a mice model of drug-induced liver injury (DILI).Material and treatmentsDILI was induced by overdose administration of acetaminophen (APAP) by oral gavage in wild-type BALB/c, ST2-deficient mice and in different bone marrow chimeras. Neutrophils were depleted by anti-Ly6G and macrophages with clodronate liposomes (CLL).MethodsBlood and liver were collected for biochemical, immunologic and genetic analyses. Mice were imaged by confocal intravital microscopy and liver non-parenchymal cells and hepatocytes were isolated for flow cytometry, genetic and immunofluorescence studies.ResultsAcetaminophen overdose caused a massive necrosis and accumulation of immune cells within the liver, concomitantly with IL-33 and chemokine release. Liver non-parenchymal cells were the major sensors for IL-33, and amongst them, neutrophils were the major players in amplification of the inflammatory response triggered by IL-33/ST2 signalling pathway.ConclusionBlockage of IL-33/ST2 axis reduces APAP-mediated organ injury by dampening liver chemokine release and activation of resident and infiltrating liver non-parenchymal cells.
immunology,cell biology
What problem does this paper attempt to address?